Joint case study profiles VHHs against CDK2/CycE1 in functional biochemical assays and finds binders acting through two distinct mechanisms
Axxam and Isogenica uncover new ways to inhibit CDK2 with VHHs Read More »
Axxam validates cardiac organoid platform developed by Molecular Devices and HeartBeat.bio for drug discovery and early derisking
Axxam validates cardiac organoid platform from Molecular Devices and HeartBeat.bio Read More »
Axxam and BiomimX collaborate to advance human-relevant drug discovery with next-generation Organ-on-Chip technologies
Axxam and BiomimX collaborate on Organ-on-Chip drug discovery Read More »
Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment
Axxam and HeartBeat.bio advance cardiovascular drug discovery Read More »
Axxam and Tessara collaborate to advance next-generation neuroscience drug discovery using human-relevant 3D models
Axxam and Tessara join forces for neuroscience drug discovery Read More »
Axxam and B’SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology
Molecular Health and Axxam enter into a strategic partnershipto bolster the discovery of innovative targets in drug development
Molecular Health and Axxam drive discovery of new drug targets Read More »
Axxam and X-Chem announce a collaboration combining deep expertise in biology and high-performance DEL screening
